Chronic Myeloid Leukemia Treatment Discontinuation
2 Visningar
• 06/27/23
0
0
Bädda in
administrator
Prenumeranter
The panelists, Jorge Cortes, MD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; Harry Erba, MD, PhD; and Javier Pinilla-Ibarz, MD, PhD, discuss under what conditions treatment discontinuation may be considered in the management of chronic myeloid leukemia.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna